Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Gross Profit |
-44.14K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | EBIT |
-3.07M | -242.69K | -159.68K | -172.47K | -207.64K | -39.34K | EBITDA |
-3.03M | -242.53K | -159.46K | -172.47K | -207.61K | -39.34K | Net Income Common Stockholders |
-3.47M | -242.53K | -159.48K | -172.76K | -207.61K | -39.34K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
48.21K | 4.77K | 48.21K | 200.35K | 363.65K | 62.57K | Total Assets |
70.49K | 15.99K | 70.49K | 208.62K | 388.84K | 62.57K | Total Debt |
10.47K | 203.19K | 10.47K | 10.47K | 10.47K | 0.00 | Net Debt |
-37.74K | 198.43K | -37.74K | -189.88K | -353.18K | -62.57K | Total Liabilities |
59.37K | 247.40K | 59.37K | 38.02K | 45.48K | 38.27K | Stockholders Equity |
11.13K | -231.41K | 11.13K | 170.60K | 343.36K | 24.30K |
Cash Flow | Free Cash Flow | ||||
-1.71M | -236.17K | -152.14K | -163.30K | -236.06K | 0.00 | Operating Cash Flow |
-1.71M | -236.17K | -152.14K | -163.30K | -236.06K | 0.00 | Investing Cash Flow |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Financing Cash Flow |
1.99M | 192.72K | 0.00 | 0.00 | 537.14K | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £1.60B | 21.09 | 15.70% | ― | 31.84% | ― | |
77 Outperform | £74.16B | 7.80 | 20.80% | 7.02% | -3.39% | 11.60% | |
62 Neutral | $11.85B | 9.13 | 8.11% | 79.54% | 12.80% | -5.24% | |
62 Neutral | £30.73B | ― | -3.81% | 3.97% | 3.11% | -137.83% | |
31 Underperform | £9.71M | ― | ― | ― | -149.21% |